Repligen (RGEN) Change in Accured Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Change in Accured Expenses data on file, last reported at -$12.7 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$12.7 million, down 800.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 153.7% YoY), and the FY2025 annual result was $11.8 million, up 93.47% from the prior year.
• Change in Accured Expenses fell to -$12.7 million in Q1 2026 per RGEN's latest filing, from $2.2 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $12.6 million in Q3 2025 and troughed at -$12.7 million in Q1 2026.
• A 5-year average of -$1.1 million and a median of -$721000.0 in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses soared 516.24% in 2024, then tumbled 800.33% in 2026.
• A 5-year view of Change in Accured Expenses shows it stood at -$5.1 million in 2022, then plunged by 77.87% to -$9.0 million in 2023, then jumped by 108.29% to $746000.0 in 2024, then surged by 192.76% to $2.2 million in 2025, then plunged by 679.44% to -$12.7 million in 2026.
• Business Quant data shows RGEN's Change in Accured Expenses at -$12.7 million in Q1 2026, $2.2 million in Q4 2025, and $12.6 million in Q3 2025.